Immune Regulatory Articles & Analysis
2 news found
For example, some patients with small cell lung cancer, gastric/gastroesophageal junction cancer, biliary tract cancer and triple-negative breast cancer are resistant to conventional checkpoint inhibitor monotherapy, as their low immune infiltrates or lack of antigen recognition prevent them from properly respond to the therapy. ...
Indee Labs is actively growing its Early Access Program for the development of the µVS Delivery SystemTM for the discovery, development and manufacturing of modified immune cells. The team is working with the National Cancer Institute to add a transgene insertion kit to the program in 2021, while also demonstrating improved in vivo function of modified ...